SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-018354
Filing Date
2021-04-09
Accepted
2021-04-09 16:45:07
Documents
8
Period of Report
2021-04-09

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210409.htm 6-K 17593
2 EX-99.1 bntx-ex991_7.htm EX-99.1 48410
3 GRAPHIC gwzwuncd4uz4000003.jpg GRAPHIC 804
4 GRAPHIC gwzwuncd4uz4000002.jpg GRAPHIC 804
5 GRAPHIC gcb5msuciz4b000002.jpg GRAPHIC 16250
6 GRAPHIC gcb5msuciz4b000001.jpg GRAPHIC 41593
7 GRAPHIC gwzwuncd4uz4000004.jpg GRAPHIC 804
8 GRAPHIC gwzwuncd4uz4000001.jpg GRAPHIC 804
  Complete submission text file 0001564590-21-018354.txt   151955
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21818318
SIC: 2836 Biological Products, (No Diagnostic Substances)